REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/24/2025
Back to search
Official data from USPTO
A
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
11/25/2025
Trademark type
Combined
Nice classes
42
Filing date
01/10/2020
Registration date
11/24/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/24/2020
Last transaction
11/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
12/10/2019
First use in commerce
12/10/2019
Drawing code
3
Owner type
03
Owner location
Bedford, MA
Examiner
FICKES,JERI J
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized letter "A" within an incomplete ellipse with a chevron used for the cross bar in the letter.
Holders and representatives
Holders
Adept Therapeutics Inc.
Representatives
Adept Therapeutics Inc.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Biological research; Biotechnology research; Consultancy pertaining to pharmacology; Consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; Consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Chemicalbiochemicalbiological and bacteriological research and analysis; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Product development consultation; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing laboratory research services in the field of gene expressioncancer biology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development services in the field of antibodies; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/24/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/08/2020
PUBO
PUBLISHED FOR OPPOSITION
09/08/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/19/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/04/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/14/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/13/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/13/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/30/2020
GNRT
NON-FINAL ACTION E-MAILED
03/30/2020
CNRT
NON-FINAL ACTION WRITTEN
03/30/2020
DOCK
ASSIGNED TO EXAMINER
03/29/2020
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/17/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/16/2020
NWAP
NEW APPLICATION ENTERED
01/14/2020
Continuous trademark protection
Get notified about every new filing that threatens A or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.